- Direction
- Inflecting
- Own history
- —
- Peers
- 44th
- Persistence
- REVERSING
· Chemicals & Allied Products
RESEARCH SNAPSHOTBALCHEM CORP's latest supported as-filed period reports revenue of $290.7M. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
Separate current dimensions—not a universal score or investment ranking.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 24.00% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 8.63% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 60.90% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 36.37% · CORE
Level · gp.fundamentals.operating_margin
Raw value 21.48% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 1.84% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Inventory increased 33.7%; Inventory / revenue moved 1140 bp higher.
2 evidence-backed componentsThis cluster groups 3 independently calculated changes: Revenue increased 11.2%; Operating margin moved 72 bp higher; Operating income increased 15.1%.
3 evidence-backed componentsThis cluster groups 3 independently calculated changes: Revenue increased 8.6%; Operating margin moved 108 bp higher; Operating income increased 14.4%.
3 evidence-backed componentsThis cluster groups 2 independently calculated changes: Cash & equivalents increased 1.8%; Operating cash flow increased 6.4%.
2 evidence-backed componentsThis cluster groups 2 independently calculated changes: Cash & equivalents decreased 3.4%; Operating cash flow decreased 1.1%.
2 evidence-backed componentsInventory changed +33.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
BCPC · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0000009326-26-000035SEC ↗8-KOct 23, 2026Period Oct 23, 20260000009326-26-000032SEC ↗10-QJul 31, 2026Period Jun 30, 20260000009326-26-000028SEC ↗8-KJul 31, 2026Period Jul 31, 20260000009326-26-000026SEC ↗8-KJul 27, 2026Period Jul 24, 20260001140361-26-029658SEC ↗8-KJun 22, 2026Period Jun 18, 20260001140361-26-025971SEC ↗10-QApr 30, 2026Period Mar 31, 20260000009326-26-000018SEC ↗8-KTransaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Feb 12, 2026Filed Feb 13, 2026 | van Gunsteren Job LeonardSVP and GM, Specialty Products | Tax WithholdingDirect | 58 | $177 | $10,294 | Form 4 ↗ |
| Feb 11, 2026Filed Feb 13, 2026 | van Gunsteren Job LeonardSVP and GM, Specialty Products | Grant Or AwardDirect | 430 | $0 | $0 | Form 4 ↗ |
| Feb 11, 2026Filed Feb 13, 2026 | van Gunsteren Job LeonardSVP and GM, Specialty Products | Grant Or AwardDirect | 1,345 | $0 | $0 | Form 4 ↗ |
| Feb 11, 2026Filed Feb 13, 2026 | van Gunsteren Job LeonardSVP and GM, Specialty Products | Tax WithholdingDirect | 756 | $179 | $135,082 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Raw value 1.73% · OPTIONAL
Current liabilities changed +29.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current assets changed +17.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Shares outstanding changed -1.9% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Shares outstanding changed -1.8% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Current ratio changed -9.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Operating income changed +15.1% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-09-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0000009326-26-000016| van Gunsteren Job LeonardSVP and GM, Specialty Products |
| Grant Or AwardDirect |
| 1,600 |
| $0 |
| $0 |
| Form 4 ↗ |